Patient and public involvement in pharmacoepidemiological research: An environmental scan of an emerging area
Background
Patient and Public Involvment (PPI) as a partner in health research is now widely supported and promoted worldwide. It is recognized as a necessary condition for high-quality research. PPI in research projects can be conducted at all stages of research. Indeed, patients can participate in prioritizing research questions, drafting the protocol and its implementation, interpreting results, or writing dissemination documents.
Pharmacoepidemiological research is a domain where patient involvement is still in its nascent stages. Such involvement could provide more comprehensive data on drug exposure, outcomes, or risk factors. However, patient engagement remains limited in pharmacoepidemiological research utilizing large databases, with liitle scientific documentation on this thematic.
Objectives
The IMPLIQ study aims to describe the process of patient involvement in pharmacoepidemiological studies using databases, through an environmental scan composed of two distinct components.
Part 1: Systematic review of litterature
Describe the process of stakeholder involvement in pharmacoepidemiological research from January 2010 to June 2023 through a systematic literature review.
- Profile of included stakeholders;
- Research stages in which patients are involved;
- Stakeholder recruitment method;
- Methods of involvement (focus groups, workshops, committee members, etc.);
Secondary objectives :
- Identify areas of pharmaco-epidemiological research where stakeholder involvement is a preferred option
- Identify the enablers and barriers to stakeholder involvement in pharmacoepidemiological research as reported by research teams.
Part 2: Cross-sectional survey of French pharmacoepidemiology research teams
Describe the frequency and, where applicable, the level of patient involvement in pharmacoepidemiological research conducted by specialized French teams, using healthcare consumption databases.
Secondary objectives
- Describe the methods used to involve patients in pharmacoepidemiological research.
- Describe the degree of knowledge, the intention and the tools needed to engage in this patient involvement process.
- Analyze the enablers and barriers perceived by research teams regarding patient involvement in pharmacoepidemiological research.
Communications
Poster presentations:
Congress of the French Society of Therapeutic Pharmacology (SFPT), 11-13 June 2024, Tours France
Involving patients in pharmaco-epidemiological research: a cross-sectional survey of practices, barriers and needs among specialist teams in France
Rigoureau Julie, Havet Anaïs, Termoz Anne, Haesebaert Julie, Viprey Marie